ConductScience.org, home

Gene · 2000

NIH grants1,476

NIH grants whose papers are about the gene, through NIH's grant-paper links.

121 to 140 of 1,476

Download this page as JSON
GrantTitleELF4 papersNewest fiscal year
R01GM029090Myosin Gene Diversity and Function12025
R01GM071779Phosphine-Catalyzed Annulations and their Applications12025
R01GM105847Activities of nucleoprotein complexes visualized in single-molecule experiments12025
R01GM144708Defining gene regulatory networks controlling cell fate12025
R01GM147165Functions of Mammalian H1 Linker Histones in Gene Regulation and Chromatin Activity12025
R01HD114814Sperm chromatin structure and remodeling during spermiogenesis and fertilization12025
R01HL105826Fast myosin binding protein-C and cardiac contractility in heart failure12025
R01HL109557Mechanisms and Consequences of Gene Induction by Glucocorticoids in Airway Smooth Muscle12025
R01HL134817Causal variant association mechanisms in TCF21 binding coronary disease loci12025
R01HL139006Biophysical Modulation of Cardiac Ion Channels by MicroRNA12025
R01HL139478The SMAD3 signaling network in coronary artery disease risk12025
R01HL160811Lcn10 in Sepsis-Induced Vascular Leakage and Heart Failure12025
R01MH101244Functional and population genetic architectures of complex disease12025
R01MH106595Psychiatric Genomics Consortium for PTSD12025
R01NS029709Excitability and Plasticity of Developing Epileptic Brain12025
R01NS088448Function of TMEM106B in Neurodegeneration12025
R01NS094399Characterizing High Frequency Oscillations as an epilepsy biomarker with Big Data tools12025
R01NS095954Lysosomal Function of Progranulin and Neurodegeneration12025
R01NS106229Harnessing YAP-TEAD Activity as Anti-Invasion Therapeutic in Human Glioblastoma12025
R01NS122746Therapeutic Targets for Niemann-Pick Type C Neurodegeneration12025

Source NIH's project filesgene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/2000/grants?page=7